Since the lymphatic system also has an immunomodulatory role to counteract cancer cells, combined with the fact that metabolism influences immune action, it is tempting to speculate that MCF-7 secretome upregulates MTHFD2 in LECs to evade and survive the immune insult. The gene discussed is MTHFD2; the disease is cancer.